Home / Health / Health Ads Banned for Menopause & PCOS Claims
Health Ads Banned for Menopause & PCOS Claims
25 Mar
Summary
- Five supplement ads making unsubstantiated health claims were banned.
- Products claimed to treat menopause and PCOS symptoms without proof.
- Watchdog AI sweep revealed misleading health claims in online ads.
Advertising watchdog bans five supplement ads for making unproven health claims regarding women's hormonal conditions. The banned advertisements promoted products that falsely claimed to treat symptoms associated with menopause and Polycystic Ovarian Syndrome (PCOS). Products from 222 Balance Me, Lunera, Minerva, and Nova Menopause Vitality were among those prohibited for asserting they could prevent or cure menopause symptoms.
Separately, PolyBiotics faced similar action, with its ads and website suggesting its supplements could treat PCOS. The Advertising Standards Authority (ASA) highlighted that these misleading claims could exploit health worries and steer individuals away from necessary medical attention. The ASA utilized an AI-powered sweep to identify these emerging issues with online health advertising.
Several companies acknowledged their advertising language may have inadvertently implied disease or symptom treatment. 222 Collective stated they were a new business learning advertising regulations, while Lunera and PolyBiotics accepted their claims were not permitted for food supplements. Minerva and Nova did not respond to the ASA's inquiries. The ASA emphasized that accurate information is crucial for women's health and pledged continued monitoring of the sector.
